Prolonged analgesia and decreased toxicity with liposomal morphine in a mouse model. 1994

G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
Department of Anesthesiology, New York University Medical Center, New York 10016.

Inadequate control of postoperative pain remains a major clinical problem. A reliable method of providing long-lasting postoperative analgesia with a single dose would be very useful. We synthesized a liposomal morphine formulation and compared it to free morphine with regard to duration of analgesia in the mouse. Analgesia was assessed after intraperitoneal injection using the tail-flick test. The systemic toxicity after administration of liposomal and free morphine was compared. The release rate of morphine from liposomes in vitro was also evaluated. The lethal intraperitoneal dose of free morphine in 50% of mice (LD50) was 400 mg/kg. The maximum safe (non-lethal) dose of free morphine was 130 mg/kg. The highest dose of liposomal morphine administered (1650 mg/kg) did not cause death in any animal. Duration of analgesia was significantly prolonged with the highest dose of liposomal morphine (21.5 +/- 5.3 h) compared to the maximum safe dose of free morphine (3.7 +/- 0.75 h), P < 0.01. In vitro experiments showed a slow release rate of morphine from the liposome depot. Prolonged analgesia and decreased systemic toxicity for liposomal morphine are explained by sustained release of morphine from the liposomal depot. These results suggest that liposomal narcotic formulations may provide prolonged analgesia with single-dose administration.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000698 Analgesia Methods of PAIN relief that may be used with or in place of ANALGESICS. Analgesias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
September 1995, Anesthesia and analgesia,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
May 1982, RN,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
November 2008, Molecular pain,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
March 1982, Vestnik khirurgii imeni I. I. Grekova,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
May 2017, Nanomedicine (London, England),
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
September 1996, Pharmacology,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
September 1985, Kardiologiia,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
January 2007, Nihon rinsho. Japanese journal of clinical medicine,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
December 1994, Antimicrobial agents and chemotherapy,
G J Grant, and K Vermeulen, and M I Zakowski, and M Stenner, and H Turndorf, and L Langerman
January 2017, Clinical orthopaedics and related research,
Copied contents to your clipboard!